Status:
WITHDRAWN
Screening for Obstructive Sleep Apnea in Medical Patients
Lead Sponsor:
Jordan Collaborating Cardiology Group
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
18+ years
Brief Summary
Obstructive sleep apnea (OSA) is highly prevalent in the general population and is associated with multiple adverse cardiovascular consequences. Screening for OSA is recommended in those with typical...
Detailed Description
Obstructive sleep apnea (OSA) is a disease that is highly prevalent in all communities and is associated with adverse cardiovascular events. Screening for OSA is recommended in men and women who have...
Eligibility Criteria
Inclusion
- Willing to sign an informed consent
- Patient is admitted to the medical ward in a tertiary hospital
Exclusion
- Patients known to have obstructive sleep apnea.
- Patients younger than 18 years of age
Key Trial Info
Start Date :
October 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 22 2025
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05980936
Start Date
October 15 2023
End Date
February 22 2025
Last Update
February 25 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Ayman Hammoudeh
Amman, Jordan, 11184
2
Istishari Hospital
Amman, Jordan, 11888